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Abstract

Since the completion in 2003 of the Human Genome Project’s initial goal to map all the genes and discover
the complete nucleotide sequence in the human genome, opportunities for many significant medical advances
have opened up to us, including gene therapies for various genetically-linked medical disorders, the ability to
create “custom-made” drugs, and early, reliable diagnosis of genetic predispositions to disease. Genetic testing,
the inspection of a person’s DNA to identify mutated sequences, is medically relevant for individuals.
However, along with the undeniable benefits this knowledge brings, serious questions have arisen concerning
how this knowledge should be handled to protect the rights of individuals. Two major areas of concern are the
“privacy and confidentiality of genetic information, and fairness in the use of genetic information by insurers,
employers, courts, schools, adoption agencies, and the military” as noted on the Human Genome Project
website (www.ornl.gov/hgmis). Obviously, as we noted in the case study, information gained from genetic
testing may be abused. This paper will examine the role of healthcare professionals to ensure that such
information remains protected. We will then discuss the moral responsibility to handle genetic information in
an ethical manner. We will reflect on the traditional principles of medical ethics derived from the Hippocratic
Oath to inform our thinking. Finally, we will briefly examine the laws and legal protections for individuals and
their genetic information that have already been established.
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t is the year 2021, and Ginger has just walked out of a job interview with Mr. Abe Horrent,
recruiter for the modest-sized firm Gross & Inequity, Inc. While Ginger hops into her car
feeling great about her interview and confident that she will get this job, Abe runs a credit
history check, criminal background check, and a genetic profile check. The Genetic Profile is a
new innovation, available to the public thanks to the hard work of the Human Genome Project
researchers who have been able, after many years, to identify the genes responsible for every
genetically caused/influenced disease and disorder known to man. This database allows people
to view their genetic profiles (if they had genetic testing done) by searching with their social
security number. Of course, employers also have access to this database, but the law prohibits
job discrimination on the basis of information gained from genetic profiles. Now, Abe Horrent
discovers that Ginger is homozygous for the DQB1-0602 allele, the primary genetic risk factor
for narcolepsy, a sleep disorder characterized by excessive day-time sleepiness, irresistible sleep
attacks, and cataplexy (episodes of paralysis in skeletal muscles). She also possesses other genes
known as links to narcolepsy. Abe searches for “narcolepsy” on Google, and discovers that
narcoleptics often need long naps in the middle of the day to manage their symptoms. Because
the position is a desk job, there would be no risk of physical harm to her or her co-workers as a
result of the disorder. Yet the possibility of her need for daily naps would greatly decrease her
productivity. Abe Horrent decides to hire someone else to fill the position, even though Ginger is
the most qualified candidate.
Since the completion in 2003 of the Human Genome Project’s initial goal to map all the genes
and discover the complete nucleotide sequence in the human genome, opportunities for many
significant medical advances have opened up to us, including gene therapies for various
genetically-linked medical disorders, the ability to create “custom-made” drugs, and early,
reliable diagnosis of genetic predispositions to disease. Genetic testing, the inspection of a
person’s DNA to identify mutated sequences, is medically relevant for individuals. However,
along with the undeniable benefits this knowledge brings, serious questions have arisen
concerning how this knowledge should be handled to protect the rights of individuals. Two
major areas of concern are the “privacy and confidentiality of genetic information, and fairness
in the use of genetic information by insurers, employers, courts, schools, adoption agencies, and
the military” as noted on the Human Genome Project website (www.ornl.gov/hgmis).
Obviously, as we noted in the case study, information gained from genetic testing may be
abused. This paper will examine the role of healthcare professionals to ensure that such
information remains protected. We will then discuss the moral responsibility to handle genetic
information in an ethical manner. We will reflect on the traditional principles of medical ethics
derived from the Hippocratic Oath to inform our thinking. Finally, we will briefly examine the
laws and legal protections for individuals and their genetic information that have already been
established.
The Hippocratic Oath has been the basis of medical ethics for the last two thousand five hundred
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years. Found in the Corpus Hippocraticum, the Oath outlines the duties and relationship of the
physician to the illness, the patient, and to other physicians. The Hippocratic relationship
between patient and physician has been especially formative in the history of medicine.
Physicians are to treat all persons with the same respect and care (distributive justice), act in the
best interest of the patient (beneficence), and to not harm the patient (non-maleficence).
Confidentiality flows out of these principles: “What I may see or hear … in regard to the life of
men, which on no account one must spread abroad, I will keep to myself, holding such things
shameful to be spoken about” (Antoniou, 2010, p. 3077). Confidentiality protects patients; as
healers, physicians should be ashamed to divulge their secrets.

Breaches of confidentiality break the Oath's ethical standards. There are many examples of
"social stigmatization, loss of employment, or compromise of legal status" that occur because of
poor or inappropriate judgments in this area (Hill, 2003, p. 1140). The emotional distress caused
by the physician's lack of confidentiality is not an act of beneficence, but an act of maleficence,
even if it is unintentional. Furthermore, distributive justice is denied when a physician
specifically discusses patients with particular afflictions, including genetic diseases, with a third
party (Hill, 2003). The values of the Hippocratic Oath all rely on the maintenance of
confidentiality.
Patients expect physicians to not break confidentiality, and if they do, to be punished, according
to a 2003 study by Plantinga and colleagues. Her team interviewed six-hundred and two
individuals afflicted with a genetic condition, a serious non-genetic medical condition, or at risk
of developing a medical condition based upon strong family history. Nearly all those
interviewed disapproved of the idea of physicians providing personal medical information to
health insurance companies (82.4%) and employers (96.61%) without permission. In fact, a
majority of subjects believed that doctors should be punished for providing such information to
insurance companies (72.9, average) and employers (80.3%, average). Patients desire the
autonomy to control the release of their medical information but "generally trust their providers
to release their information to the proper people and for the right reasons." (Plantinga, et al,
2003, p. 58).
Physicians sharing medical information, including genetic information, with third parties
without express permission ruins the fiduciary relationship described in the Oath. The trust
patients have in their physician to responsibly manage their personal information is broken.
Without trust, the relationship between physician and patient is unharmonious and patients can
no longer entrust their wellbeing to the physician. Physicians are shackled by the autonomy of a
distrustful patient and cannot act on their behalf. The Hippocratic principles are needed to
guarantee patient welfare and the vocation of the physician (Antoniou, et al, 2010).
Today, there is significant pressure to disarm the Hippocratic Oath. Many medical schools have
altered the Oath with the "goal of creating a socially benign oath" with "nonbinding guidelines"
so that it "would not serve to restrain the conscience" (Smith, 2008, p. 3). Safeguards against
patient harm have been replaced with a legal duty to warn third parties. In the case Tarasoff v
Regents of the University of California, physicians were held responsible to protect not the
patient but any third party who might be harmed by the patient (Regan, Alderson, & Regan,
2002). This harm is vague and could be used to defend not employing an individual who might
cause economic harm to a company. A duty to warn third parties and a weak Oath undermines
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the physician’s responsibility to demonstrate beneficence and threatens to ruin the practice of
distributive justice. Other safeguards need to be present.

3

Recent laws have attempted to protect a person’s right to privacy concerning genetic
information. These laws are not water-tight, but they consider genetic discrimination to be
wrong. The Genetic Information Nondiscrimination Act (GINA), probably the most important
effort to protect genetic information, was signed by President Bush in 2008. GINA makes it
illegal for an employer to make a decision on a potential employee — or for a health insurance
agency to determine eligibility — based on genetic factors (Francis, 2010; Hudson, 2008).
While GINA protects genetic information to some degree, there are still ways to “get around” it.
For example, The Family Medical Leave Act (FMLA) allows an employee to request leave to
receive medical treatment (or to care for a family member who is receiving medical treatment),
but GINA allows the employer to require confirmation of the necessity of the leave, such as the
employee’s medical history (Francis, 2010). Also, GINA does nothing to prevent genetic
information from being obtained indirectly; people can be genetically discriminated against even
if they have never actually had genetic testing. According to one report, “A guy I knew had an
identical twin brother who had liver disease and died. The guy I knew was asymptomatic, but
couldn’t get life insurance at the normal rate. He didn’t have to be tested. If his identical twin had
it, he had it” (Klitzman, 2010, p. 74). Additionally, discrimination does not always occur in an
outright fashion. Klitzman also relates the example of an employer intentionally giving someone
projects that are less desirable because of some genetic abnormality — this would be another,
harder to prove, form of discrimination.
There are some things that GINA does not even attempt to address. GINA does not contain any
prohibitions for genetic discrimination concerning life or long-term care insurance (Hudson,
2008). It also does not require employers to make accommodations for those who have a genetic
predisposition to a problem that may be made worse by environmental factors. Because these
individuals are currently asymptomatic, they would not be covered by the Americans with
Disabilities Act. This could be considered a type of discrimination as well, because a person who
knows that exposure to certain things will exacerbate his condition will naturally want to limit
that exposure, and if his workplace will not accommodate him, he may have to quit (Klitzman,
2010).
Individual states have also enacted their own laws concerning genetic privacy and
discrimination. GINA does not abolish state laws; it acts with them to provide more protection
(Hudson, 2008). Executive Order 13,145 (which protects only federal employees) was issued in
2000. “The order bars federal employers from obtaining or disclosing „protected genetic
information,‟ which includes information about the genetic tests of an individual or her family
members, or information about the occurrence of a disease, medical condition or disorder in the
individual’s family members.” It also states that federal employers cannot discriminate in any
way on the basis of genetic information. The order does, however, give permission for federal
employers to request access to genetic information in certain circumstances (Eltis, 2007, p. 286).
Even though there are legal protections against genetic discrimination, people must be informed
for these protections to be effective. If a person gives permission for his health information to be
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released, he needs to insist on protection for his genetic information. People also need to know
they are not required to undergo genetic tests if asked to do so by an insurance company. At the
very least, they should specifically ask how results from such tests will be stored (Francis, 2010;
Hudson, 2008).

The ability to discover genetic information about ourselves through genetic testing is a
wonderful thing and holds promise for future medical and scientific advances. However, this
wealth of information is also subject to abuse, and that abuse could have a devastating impact on
the lives of individuals. Physicians and other medical professionals, who have the most ready
access to the genetic information of patients, have the moral responsibility to guard their
patients‟ well-being. They have a duty to preserve and encourage the patient flourishing by
respecting patient autonomy, showing beneficence, refraining from maleficence, and treating all
patients in a just manner. They have a huge role to play in safe-guarding genetic information and
ensuring that it is used in an ethical manner.
As we discussed, several laws already protect genetic information, but they fall short of
completely eliminating the possibility for discrimination. A re-examination of current statutes is
needed, and perhaps revisions are in order. There is much at stake: whether or not we take steps
now to ensure the safety of genetic information will greatly influence what sort of ethical
monsters we may deal with in the coming decades.
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